People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis

Letter Infectious Diseases

Intention to vaccinate against COVID-19 in Australia

Anthea Rhodes et al.

LANCET INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

A global survey of potential acceptance of a COVID-19 vaccine

Jeffrey V. Lazarus et al.

Summary: Survey data from 19 countries reveals varying attitudes towards acceptance of a COVID-19 vaccine, with trust in government being linked to vaccine confidence.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

J. Sadoff et al.

Summary: The study conducted a multicenter, placebo-controlled, phase 1-2a trial, with participants randomly assigned to receive the Ad26.COV2.S vaccine. The results showed that the safety and immunogenicity profiles of the vaccine support further development.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Immunology

Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review

Cheryl Lin et al.

Summary: While COVID-19 continues to spread globally, there is a decrease in vaccine acceptance rates, with significant demographic, socioeconomic, and partisan differences. Perceived risk, concerns over vaccine safety and effectiveness, and doctors' recommendations are key factors influencing vaccination decisions. Unique COVID-19 factors include political orientation, doubts about the expedited vaccine development process, and perceived political interference.

VACCINES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff

Radhika Gharpure et al.

Summary: This JAMA Insights review presents data on the number of long-term care facilities and the numbers of residents and staff who received first-dose vaccination through the public-private partnership with CVS, Walgreens, and Managed Health Care Associates. This data helps understand the progress of vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Add to Collection

Editorial Material Urology & Nephrology

COVID-19 vaccines and kidney disease

Martin Windpessl et al.

Summary: Patients with kidney diseases should have priority for COVID-19 vaccination and highly potent vaccines are preferred due to lower vaccine responses in this population.

NATURE REVIEWS NEPHROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Countermeasures against COVID-19: how to navigate medical practice through a nascent, evolving evidence base - a European multicentre mixed methods study

Fabian Eibensteiner et al.

Summary: A study by the European Pediatric Dialysis Working Group found that COVID-19 countermeasure implementation rates varied widely across different countries and institutions, influenced by local regulations and perceived resources. The data highlights the importance of ongoing assessment of current practices to facilitate rapid adjustments in response to emerging evidence of countermeasure efficacy.

BMJ OPEN (2021)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

Michael Schwarzinger et al.

Summary: This study highlights that COVID-19 vaccine acceptance is influenced by the characteristics of new vaccines and national vaccination strategies, as well as factors such as gender, age, education level, and past vaccination history. In the working-age population in France, the outright vaccine refusal rate is approximately 29.4%, while vaccine hesitancy is influenced by vaccine characteristics and information on herd immunity benefits.

LANCET PUBLIC HEALTH (2021)

Add to Collection

Article Information Science & Library Science

It doesn't take a village to fall for misinformation: Social media use, discussion heterogeneity preference, worry of the virus, faith in scientists, and COVID-19-related misinformation beliefs

Yan Su

Summary: This study explored the impact of social media use and discussion heterogeneity preference on COVID-19-related misinformation beliefs through a national survey in the United States. Results indicated that social media use was positively associated with misinformation beliefs, while discussion heterogeneity preference was negatively associated. Furthermore, worry of COVID-19 was found to be a significant mediator and faith in scientists served as a moderator that mitigated the indirect effect of discussion heterogeneity preference on misinformation beliefs.

TELEMATICS AND INFORMATICS (2021)

Add to Collection

Editorial Material Public, Environmental & Occupational Health